SHORT LEVERAGE - MERCK & CO. Stock

Certificat

7U96S

DE000SV4KHQ4

Market Closed - Euronext Paris 10:59:03 2024-01-24 EST
0.983 EUR -0.10% Intraday chart for SHORT LEVERAGE - MERCK & CO.
1 month-8.13%
3 months-15.04%

Static data

Product typeProduits Exotiques
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
7U96S
ISINDE000SV4KHQ4
Date issued 2023-04-21
Maturity Unlimited
Parity 1 : 1
Emission price 1
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.207
Lowest since issue 0.95

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8 USD
Average target price
142.7 USD
Spread / Average Target
+15.25%
Consensus
  1. Stock Market
  2. Certificates
  3. 7U96S Certificat